[1]
Szkatuła, W. et al. 2026. EFFICACY AND SAFETY OF MAVACAMTEN IN HYPERTROPHIC CARDIOMYOPATHY – A SYSTEMATIC REVIEW OF CURRENT CLINICAL STUDIES. International Journal of Innovative Technologies in Social Science. 5, 2(50) (Jun. 2026). DOI:https://doi.org/10.31435/ijitss.2(50).2026.5881.